September 7, 2016
Kenporen Director Shoji Kono The reimbursement price of Opdivo (nivolumab) should be slashed through a new special re-pricing rule for fast-growing blockbusters without waiting for the next drug price revision scheduled for April 2018, Shoji Kono, director of the National...read more